$PARS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PHARMOS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PHARMOS CORP. Get notifications about new insider transactions in PHARMOS CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 01 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Sell | S | 4.11 | 30,000 | 123,168 | 334,252 | 364.3 K to 334.3 K (-8.24 %) |
Dec 01 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Sell | S | 4.12 | 20,000 | 82,426 | 364,252 | 384.3 K to 364.3 K (-5.20 %) |
Dec 01 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Buy | M | 1.88 | 37,500 | 70,313 | 384,252 | 346.8 K to 384.3 K (+10.81 %) |
Dec 01 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Buy | M | 1.02 | 23,437 | 23,906 | 346,752 | 323.3 K to 346.8 K (+7.25 %) |
Dec 01 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Buy | M | 1.90 | 62,500 | 118,750 | 323,315 | 260.8 K to 323.3 K (+23.96 %) |
Dec 01 2004 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Option Exercise | M | 2.50 | 139,376 | 348,440 | 0 | |
Dec 01 2004 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Option Exercise | M | 1.94 | 60,000 | 116,250 | 0 | |
Dec 01 2004 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Sell | S | 4.13 | 139,376 | 576,013 | 852,726 | 992.1 K to 852.7 K (-14.05 %) |
Dec 01 2004 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Buy | M | 2.50 | 139,376 | 348,440 | 992,102 | 852.7 K to 992.1 K (+16.34 %) |
Dec 01 2004 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Sell | S | 4.11 | 60,000 | 246,750 | 852,726 | 912.7 K to 852.7 K (-6.57 %) |
Dec 01 2004 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Buy | M | 1.94 | 60,000 | 116,250 | 912,726 | 852.7 K to 912.7 K (+7.04 %) |
Nov 29 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Option Exercise | M | 1.75 | 15,000 | 26,250 | 0 | |
Nov 29 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Option Exercise | M | 1.02 | 3,750 | 3,825 | 16,250 | |
Nov 29 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Option Exercise | M | 1.88 | 10,000 | 18,750 | 10,000 | |
Nov 29 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Sell | S | 3.99 | 15,000 | 59,853 | 0 | 15 K to 0 (-100.00 %) |
Nov 29 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Buy | M | 1.75 | 15,000 | 26,250 | 15,000 | 0 to 15 K |
Nov 29 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Sell | S | 3.99 | 3,750 | 14,954 | 0 | 3.8 K to 0 (-100.00 %) |
Nov 29 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Buy | M | 1.02 | 3,750 | 3,825 | 3,750 | 0 to 3.8 K |
Nov 29 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Sell | S | 4.01 | 10,000 | 40,123 | 0 | 10 K to 0 (-100.00 %) |
Nov 29 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Buy | M | 1.88 | 10,000 | 18,750 | 10,000 | 0 to 10 K |
Nov 16 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Option Exercise | M | 2.50 | 37,632 | 94,080 | 1,701 | |
Nov 16 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Option Exercise | M | 1.94 | 40,000 | 77,500 | 0 | |
Nov 16 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Option Exercise | X | 1.59 | 2,368 | 3,765 | 0 | |
Nov 16 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Sell | S | 3.83 | 511 | 1,957 | 260,815 | 261.3 K to 260.8 K (-0.20 %) |
Nov 16 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Sell | S | 3.82 | 800 | 3,056 | 261,326 | 262.1 K to 261.3 K (-0.31 %) |
Nov 16 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Sell | S | 3.81 | 5,600 | 21,336 | 262,126 | 267.7 K to 262.1 K (-2.09 %) |
Nov 16 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Sell | S | 3.80 | 300 | 1,140 | 267,726 | 268 K to 267.7 K (-0.11 %) |
Nov 16 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Sell | S | 3.80 | 72,789 | 276,598 | 268,026 | 340.8 K to 268 K (-21.36 %) |
Nov 16 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Buy | M | 2.50 | 37,632 | 94,080 | 340,815 | 303.2 K to 340.8 K (+12.41 %) |
Nov 16 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Buy | M | 1.94 | 40,000 | 77,500 | 303,183 | 263.2 K to 303.2 K (+15.20 %) |
Nov 16 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Buy | X | 1.59 | 2,368 | 3,765 | 263,183 | 260.8 K to 263.2 K (+0.91 %) |
Nov 15 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | M | 1.88 | 8,750 | 16,406 | 7,500 | |
Nov 15 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Sell | S | 3.88 | 8,750 | 33,906 | 0 | 8.8 K to 0 (-100.00 %) |
Nov 15 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Buy | M | 1.88 | 8,750 | 16,406 | 8,750 | 0 to 8.8 K |
Sep 08 2004 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Grant | A | 3.16 | 379,747 | 1,200,001 | 852,726 | 473 K to 852.7 K (+80.29 %) |
Sep 08 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Grant | A | 3.16 | 253,165 | 800,001 | 260,815 | 7.7 K to 260.8 K (+3,309.35 %) |
Aug 18 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | M | 1.02 | 1,250 | 1,275 | 11,500 | |
Aug 18 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Sell | S | 3.45 | 100 | 345 | 0 | 100 to 0 (-100.00 %) |
Aug 18 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Sell | S | 3.43 | 1,150 | 3,945 | 100 | 1.3 K to 100 (-92.00 %) |
Aug 18 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Buy | M | 1.02 | 1,250 | 1,275 | 1,250 | 0 to 1.3 K |
Jul 07 2004 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Sell | S | 3.80 | 144,153 | 547,781 | 472,979 | 617.1 K to 473 K (-23.36 %) |
Jul 07 2004 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Sell | S | 3.95 | 132,000 | 521,532 | 617,132 | 749.1 K to 617.1 K (-17.62 %) |
Jul 06 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Option Exercise | X | 1.59 | 20,000 | 31,800 | 2,368 | |
Jul 06 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Sell | S | 4.01 | 20,000 | 80,200 | 7,650 | 27.7 K to 7.7 K (-72.33 %) |
Jul 06 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Buy | X | 1.59 | 20,000 | 31,800 | 27,650 | 7.7 K to 27.7 K (+261.44 %) |
Jul 06 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | M | 1.88 | 2,500 | 4,688 | 16,250 | |
Jul 06 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Sell | S | 4.20 | 1,000 | 4,200 | 0 | 1,000 to 0 (-100.00 %) |
Jul 06 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Sell | S | 4.15 | 785 | 3,258 | 1,000 | 1.8 K to 1,000 (-43.98 %) |
Jul 06 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Sell | S | 4.12 | 715 | 2,946 | 1,785 | 2.5 K to 1.8 K (-28.60 %) |
Jul 06 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Buy | M | 1.88 | 2,500 | 4,688 | 2,500 | 0 to 2.5 K |
Jun 21 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | M | 1.88 | 1,250 | 2,344 | 18,750 | |
Jun 21 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Sell | S | 3.88 | 1,250 | 4,844 | 0 | 1.3 K to 0 (-100.00 %) |
Jun 21 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Buy | M | 1.88 | 1,250 | 2,344 | 1,250 | 0 to 1.3 K |
Jun 21 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Option Exercise | X | 1.59 | 6,400 | 10,176 | 22,368 | |
Jun 21 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Sell | S | 3.80 | 6,400 | 24,320 | 7,650 | 14.1 K to 7.7 K (-45.55 %) |
Jun 21 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Buy | X | 1.59 | 6,400 | 10,176 | 14,050 | 7.7 K to 14.1 K (+83.66 %) |
Jun 10 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Option Exercise | X | 1.59 | 13,600 | 21,624 | 28,768 | |
Jun 10 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Sell | S | 3.81 | 2,000 | 7,620 | 7,650 | 9.7 K to 7.7 K (-20.73 %) |
Jun 10 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Sell | S | 3.80 | 11,600 | 44,080 | 9,650 | 21.3 K to 9.7 K (-54.59 %) |
Jun 10 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Buy | X | 1.59 | 13,600 | 21,624 | 21,250 | 7.7 K to 21.3 K (+177.78 %) |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Option Exercise | M | 1.02 | 6,250 | 6,375 | 13,750 | |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Option Exercise | M | 1.90 | 10,000 | 19,000 | 10,000 | |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Option Exercise | M | 1.88 | 15,000 | 28,125 | 5,000 | |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Option Exercise | M | 1.25 | 7,500 | 9,375 | 2,500 | |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Option Exercise | M | 1.75 | 11,250 | 19,688 | 3,750 | |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Sell | S | 3.42 | 5,000 | 17,100 | 0 | 5 K to 0 (-100.00 %) |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Sell | S | 3.38 | 1,895 | 6,405 | 5,000 | 6.9 K to 5 K (-27.48 %) |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Sell | S | 3.32 | 5,795 | 19,239 | 6,895 | 12.7 K to 6.9 K (-45.67 %) |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Sell | S | 3.33 | 6,898 | 22,970 | 12,690 | 19.6 K to 12.7 K (-35.22 %) |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Sell | S | 3.35 | 6,305 | 21,122 | 19,588 | 25.9 K to 19.6 K (-24.35 %) |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Sell | S | 3.36 | 1,500 | 5,040 | 25,893 | 27.4 K to 25.9 K (-5.48 %) |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Sell | S | 3.37 | 3,064 | 10,326 | 27,393 | 30.5 K to 27.4 K (-10.06 %) |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Sell | S | 3.39 | 5,638 | 19,113 | 30,457 | 36.1 K to 30.5 K (-15.62 %) |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Sell | S | 3.40 | 13,905 | 47,277 | 36,095 | 50 K to 36.1 K (-27.81 %) |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Buy | M | 1.02 | 6,250 | 6,375 | 50,000 | 43.8 K to 50 K (+14.29 %) |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Buy | M | 1.90 | 10,000 | 19,000 | 43,750 | 33.8 K to 43.8 K (+29.63 %) |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Buy | M | 1.88 | 15,000 | 28,125 | 33,750 | 18.8 K to 33.8 K (+80.00 %) |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Buy | M | 1.25 | 7,500 | 9,375 | 18,750 | 11.3 K to 18.8 K (+66.67 %) |
May 27 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Buy | M | 1.75 | 11,250 | 19,688 | 11,250 | 0 to 11.3 K |
May 12 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Option Exercise | M | 1.02 | 18,368 | 18,735 | 93,750 | |
May 12 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Option Exercise | X | 1.59 | 1,632 | 2,595 | 42,368 | |
May 12 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Sell | S | 3.80 | 1,632 | 6,202 | 7,650 | 9.3 K to 7.7 K (-17.58 %) |
May 12 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Sell | S | 3.65 | 1,400 | 5,110 | 9,282 | 10.7 K to 9.3 K (-13.11 %) |
May 12 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Sell | S | 3.64 | 5,500 | 20,020 | 10,682 | 16.2 K to 10.7 K (-33.99 %) |
May 12 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Sell | S | 3.63 | 370 | 1,343 | 16,182 | 16.6 K to 16.2 K (-2.24 %) |
May 12 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Sell | S | 3.62 | 11,098 | 40,175 | 16,552 | 27.7 K to 16.6 K (-40.14 %) |
May 12 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Buy | M | 1.02 | 18,368 | 18,735 | 27,650 | 9.3 K to 27.7 K (+197.89 %) |
May 12 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Buy | X | 1.59 | 1,632 | 2,595 | 9,282 | 7.7 K to 9.3 K (+21.33 %) |
Jun 02 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | M | 1.02 | 1,250 | 1,275 | 13,750 | |
Jun 02 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Sell | S | 3.32 | 1,250 | 4,150 | 0 | 1.3 K to 0 (-100.00 %) |
Jun 02 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Buy | M | 1.02 | 1,250 | 1,275 | 1,250 | 0 to 1.3 K |
Apr 21 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Option Exercise | M | 1.02 | 12,882 | 13,140 | 112,118 | |
Apr 21 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Sell | S | 3.92 | 12,882 | 50,497 | 7,650 | 20.5 K to 7.7 K (-62.74 %) |
Apr 21 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President & COO | Buy | M | 1.02 | 12,882 | 13,140 | 20,532 | 7.7 K to 20.5 K (+168.39 %) |
Apr 15 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | X | 1.02 | 2,500 | 2,550 | 17,500 | |
Apr 15 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Sell | S | 3.93 | 2,500 | 9,825 | 0 | 2.5 K to 0 (-100.00 %) |
Apr 15 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Buy | X | 1.02 | 2,500 | 2,550 | 2,500 | 0 to 2.5 K |
May 04 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | M | 1.02 | 2,500 | 2,550 | 15,000 | |
May 04 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Sell | S | 3.85 | 2,500 | 9,625 | 0 | 2.5 K to 0 (-100.00 %) |
May 04 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Buy | M | 1.02 | 2,500 | 2,550 | 2,500 | 0 to 2.5 K |
Mar 19 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Option Exercise | X | 1.02 | 5,000 | 5,100 | 15,000 | |
Mar 19 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Option Exercise | X | 1.25 | 10,000 | 12,500 | 0 | |
Mar 19 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Sell | S | 4.00 | 15,000 | 60,000 | 0 | 15 K to 0 (-100.00 %) |
Mar 19 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Buy | X | 1.02 | 5,000 | 5,100 | 15,000 | 10 K to 15 K (+50.00 %) |
Mar 19 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Buy | X | 1.25 | 10,000 | 12,500 | 10,000 | 0 to 10 K |
Feb 26 2004 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Option Exercise | A | 4.24 | 25,000 | 106,000 | 25,000 | |
Feb 24 2004 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Option Exercise | A | 4.24 | 25,000 | 106,000 | 25,000 | |
Feb 24 2004 | PARS | PHARMOS CORP | SCHLACHET DAVID | Director | Option Exercise | A | 4.24 | 25,000 | 106,000 | 25,000 | |
Feb 24 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | A | 4.24 | 25,000 | 106,000 | 25,000 | |
Feb 24 2004 | PARS | PHARMOS CORP | MARSHALL LAWRENCE | Director | Option Exercise | A | 4.24 | 25,000 | 106,000 | 25,000 | |
Feb 24 2004 | PARS | PHARMOS CORP | COOK ROBERT W | Executive Vice Pres ... | Option Exercise | A | 4.24 | 115,000 | 487,600 | 115,000 | |
Feb 24 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Option Exercise | A | 4.24 | 135,000 | 572,400 | 135,000 | |
Feb 24 2004 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Option Exercise | A | 4.24 | 200,000 | 848,000 | 200,000 | |
Nov 10 2003 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Option Exercise | M | 1.25 | 50,000 | 62,500 | 0 | |
Nov 10 2003 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Sell | S | 4.16 | 10,000 | 41,600 | 7,650 | 17.7 K to 7.7 K (-56.66 %) |
Nov 10 2003 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Sell | S | 4.01 | 50,000 | 200,450 | 17,650 | 67.7 K to 17.7 K (-73.91 %) |
Nov 10 2003 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Buy | M | 1.25 | 50,000 | 62,500 | 67,650 | 17.7 K to 67.7 K (+283.29 %) |
Nov 12 2003 | PARS | PHARMOS CORP | COOK ROBERT W | Executive Vice Pres ... | Option Exercise | M | 1.25 | 20,000 | 25,000 | 0 | |
Nov 12 2003 | PARS | PHARMOS CORP | COOK ROBERT W | Executive Vice Pres ... | Sell | S | 4.14 | 20,000 | 82,800 | 19,000 | 39 K to 19 K (-51.28 %) |
Nov 12 2003 | PARS | PHARMOS CORP | COOK ROBERT W | Executive Vice Pres ... | Buy | M | 1.25 | 20,000 | 25,000 | 39,000 | 19 K to 39 K (+105.26 %) |
Oct 06 2003 | PARS | PHARMOS CORP | COOK ROBERT W | Executive Vice Pres ... | Option Exercise | M | 1.25 | 20,000 | 25,000 | 20,000 | |
Oct 06 2003 | PARS | PHARMOS CORP | COOK ROBERT W | Executive Vice Pres ... | Sell | S | 2.52 | 5,000 | 12,597 | 19,000 | 24 K to 19 K (-20.83 %) |
Oct 06 2003 | PARS | PHARMOS CORP | COOK ROBERT W | Executive Vice Pres ... | Sell | S | 2.55 | 15,000 | 38,250 | 24,000 | 39 K to 24 K (-38.46 %) |
Oct 06 2003 | PARS | PHARMOS CORP | COOK ROBERT W | Executive Vice Pres ... | Buy | M | 1.25 | 20,000 | 25,000 | 39,000 | 19 K to 39 K (+105.26 %) |